Skip to main content
Terug
AKTS logo

Aktis Oncology, Inc.

Datakwaliteit: 100%
AKTS
NASDAQ Healthcare Biotechnology
€ 18,63
▲ € 0,45 (2,48%)
Marktkapitalisatie: 992,92M
Dagbereik
€ 17,19 € 18,87
52-Weeksbereik
€ 16,80 € 29,16
Volume
440.081
50D / 200D Gem.
€ 19,69 / € 19,69
Vorige Slotkoers
€ 18,18

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (627 peers)

Metriek Aandeel Sector Mediaan
P/E -22,6 0,3
P/B 2,9
ROE % 3,7
Net Margin % -2957,6 3,8
Rev Growth 5Y % 10,0
D/E 0,2

Koersdoel Analisten

Hold
€ 31,00 +66.4%
Forward WPA
-€ 0,20
Omzet Sch.
62 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2026 -€ 0,20
-€ 0,21 – -€ 0,19
62 M 1

Belangrijkste Punten

Generating 11,90M in free cash flow
Capital intensive — 192,47% of revenue goes to capex

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net Margin-2957,63%
Op. Margin-3500,34%

Veiligheid

Debt / Equity
N/A
Current Ratio15,98
Interest Coverage0,00

Waardering

P/E Ratio
-22,58
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,49M Net Income (TTM) -43,98M
ROE N/A ROA -13,48%
Gross Margin 100,00% Operating Margin -3500,34%
Net Margin -2957,63% Free Cash Flow (TTM) 11,90M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 15,98
Interest Coverage 0,00 Dividend Yield 0,00%
Valuation
P/E Ratio -22,58 P/B Ratio N/A
P/S Ratio 667,74 PEG Ratio 0,00
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 992,92M Enterprise Value 967,77M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022
Revenue 1,49M 0,0 0,0
Net Income -43,98M -28,64M -17,93M
EPS (Diluted) 0,00 0,00 0,00
Gross Profit 1,49M 0,0 0,0
Operating Income -52,05M -34,79M -19,76M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022
Total Assets 326,18M 122,36M 138,32M
Total Liabilities 413,98M 168,66M 157,55M
Shareholders' Equity -87,80M -46,31M -19,23M
Total Debt 12,01M 13,40M 1,78M
Cash & Equivalents 37,16M 29,51M 128,60M
Current Assets 300,85M 100,20M 132,48M
Current Liabilities 18,82M 6,24M 5,28M